sales@contrivedatuminsights.com
CDI - Contrive Datum Insights
Chemicals & Materials

Bio-based Propylene Glycol MarketSize, Share & Industry Analysis, 2026-2034By FeedstockBy Production ProcessBy GradeBy ApplicationBy End-use IndustryBy Bio-based ContentBy Certification and Sustainability ClaimBy Producer TypeBy Plant Capacity BandBy Distribution ChannelBy Packaging Format

Full title & scope — all 11 axes with their segments

Bio-based Propylene Glycol Market Size, Share & Industry Analysis, By Feedstock (Glycerol, Sorbitol, Corn Glucose and Starch, Lactic Acid and Lactate Esters, Lignocellulosic Biomass, Other Renewable Feedstocks), By Production Process (Glycerol Hydrogenolysis, Sorbitol Hydrogenolysis, Fermentation-based Route, Lactic Acid Hydrogenation), By Grade (Industrial Grade, USP/EP Grade, Food Grade, Cosmetic Grade, Technical Grade), By Application (Unsaturated Polyester Resins, Antifreeze, Coolants and De-icing Fluids, Pharmaceutical Excipients and Solvents, Food and Beverage Additives, Personal Care and Cosmetics, Detergents and Cleaning, Paints, Coatings and Adhesives, E-cigarette and Vaping Liquids), By End-use Industry (Pharmaceuticals, Cosmetics and Personal Care, Food and Beverage, Chemicals and Plastics, Automotive and Transportation, Building and Construction, Others), By Bio-based Content (100% Bio-based, Partially Bio-based), By Certification and Sustainability Claim (USDA BioPreferred Certified, ISCC PLUS Certified, RSB Certified, Non-certified), By Producer Type (Integrated Oleochemical Producers, Agri-processors, Chemical Majors, Specialty and Start-up Producers), By Plant Capacity Band (Below 20 KTPA, 20-50 KTPA, 50-100 KTPA, Above 100 KTPA), By Distribution Channel (Direct Sales, Distributors and Traders, Online and Spot Trade), By Packaging Format (Bulk Tankers and ISO Tanks, IBC Totes, Drums, Small Packs), and Regional Forecast, 2026-2034

Last Updated: Nov 9, 2026Format: PDFReport ID: CDI-248871
Methodology

How the estimates were built: data sources, modelling approach and validation steps.

Research approach

A market size is a claim about the world, and a claim is only as good as the route to it. Every study is built upward from units and prices — what is actually produced, sold or performed, at what it actually changes hands for — rather than from a headline figure divided downwards. Disclosed company revenue is then used to check that build, not to produce it.

Market size estimation, this report

The size was built upward from production volumes and realised prices. Capacity and utilisation at bio-based propylene glycol plants, expressed in tonnes, were multiplied by contract and spot prices for each grade, then allocated across feedstock routes, applications and regions using trade flows and customs data. Imports and exports were netted to arrive at consumption by region. The result was then compared with revenue disclosed by listed producers and with the share of propylene glycol they report as bio-based. Where the bottom-up total and the disclosed revenue disagreed, the volume, utilisation or price assumption was corrected; the disclosed figures were not averaged into the estimate. Grade mix and the premium over fossil-based material were the inputs that moved the total most.

The four stages

The same sequence runs behind every published study, whatever the industry. The order matters as much as the steps: the segment axes are fixed before any number is collected, so the model is never reshaped to fit whatever data happens to turn up.

1
Scope and segmentation
2
Bottom-up sizing
3
Reconciliation
4
Forecast

What the build rests on, and what checks it

The two are not interchangeable. The left column produces the number; the right column tests it. When the check disagrees with the build, the answer is to find which bottom-up assumption is wrong — a unit count, a price, a take-up rate — not to split the difference between them.

The bottom-up build rests on
  • Volume actually transacted — units produced, installed, dispensed or procedures performed, counted at the level each is genuinely recorded
  • Realised pricing by tier and channel, rather than one blended average applied across the whole market
  • Take-up and frequency: how much of the addressable base buys, and how often it repeats
The build is checked against
  • Disclosed revenue of the companies serving the market, where filings separate it far enough to be usable
  • Buyer-side spending totals — capital budgets, procurement lines, or the output of the end market the product is bought against
  • Trade and customs flows, where the product crosses borders in a separately recorded form
Bottom-up sequence
1
Size the base
2
Apply take-up
3
Apply frequency
4
Apply realised price
Reconciliation sequence
1
Gather disclosed revenue
2
Strip out-of-scope lines
3
Compare against the build
4
Correct the assumption

Data sources

Published data establishes what happened. Only the people transacting in a market can say why, and what is about to change — so the two are collected separately and weighted differently.

Primary — who is interviewed
  • Commercial and product leadership at the companies that supply the market
  • Procurement and specification leads at the organisations that buy it
  • Distributors, integrators and channel partners, where the market is served indirectly
  • Regulatory and standards specialists, where approval governs what can be sold at all
Secondary — what is read
  • Company filings, annual reports and investor disclosure
  • Government statistics, customs records and regulatory registers
  • Trade association output and standards-body publications
  • Technical and peer-reviewed literature, where the market rests on a clinical or engineering claim
Primary research design, this report

Interviews were directed at the roles that set demand and price in this market: procurement and sourcing leads at pharmaceutical, personal care and food manufacturers; technical managers at unsaturated polyester resin and coolant formulators; plant and commercial managers at glycerol-based and fermentation-based producers; distributors handling bulk and drummed material; and regulatory specialists familiar with USP, EP and food-grade requirements and with bio-based certification schemes. Sampling emphasised Europe and North America, where certified demand is deepest, and China, India and Southeast Asia, where capacity and feedstock supply are expanding. Conversations were used to test volume, grade mix, price premiums and contract terms against the desk-based build.

Secondary sources, this report

Desk research rested on customs tariff data under HS 2905.32 for propylene glycol, which separates trade flows by country, and on biodiesel and oleochemical output statistics that determine crude glycerol availability. Pharmacopoeia monographs (USP and EP) and the food additive listing for E1520 define the grade requirements. Certification registers for USDA BioPreferred, ISCC PLUS and RSB identify certified supply, while REACH registration dossiers, company annual reports, investor presentations and plant announcements supply capacity, utilisation and product mix. Trade association statistics on biodiesel and sugar processing complemented these for feedstock cost trends.

Desk research runs across proprietary research databases including Factiva, OneSource and Hoovers alongside the public sources above. Modelling and statistical validation are run in SAS and SPSS.

Forecasting

The forecast is not a growth rate applied to a base year. It is built from the drivers that are expected to change, each one stated so a reader can disagree with it.

Forecast approach, this report

The forecast is driven by volume growth in pharmaceutical, cosmetic and food applications, gradual substitution of fossil-based material in resins, coolants and detergents, and the pace at which fermentation and lactic acid routes add capacity beyond glycerol hydrogenolysis. Prices follow feedstock cost and the premium buyers will pay for certified bio-based content. Short-term swings in crude glycerol supply and in oil-linked propylene glycol prices were normalised so that a single year does not set the trend. For the forecast to hold, biodiesel output must keep glycerol available at stable cost, renewable content targets must stay in force, and announced plants must reach nameplate output on schedule.

Triangulation and validation

No figure enters a report on the strength of one source. Where the two sizing routes disagree the difference is not averaged away — the assumption causing it is isolated, tested against a third independent measure, and either corrected or carried forward as a stated limitation. Historical years are back-tested against the growth actually recorded before any forecast is allowed to run forward from them.

Validation, this report

The estimate was back-tested against recorded growth in propylene glycol trade volumes and in producers' reported bio-based sales across 2020 to 2024. Segment shifts, in particular the move toward fermentation-based supply and pharmaceutical grades, were reviewed with industry specialists. Sensitivities were run on the realised price premium over fossil-based material, on plant utilisation, and on the share of certified supply. Regional totals were reconciled with national trade data, and each axis was checked to sum to the scope total in the base year and in 2034. Bull and bear cases were set by moving feedstock cost, premium and capacity timing together.

Confidence and limitations

Where an estimate is firm and where it is not is stated rather than left to be inferred from the precision of the number.

Confidence framing, this report

The estimate is firmest for glycerol-based supply, for the pharmaceutical and food grades, and for North America and Europe, where trade data and producer disclosures overlap. It is thinner for fermentation-based output, for producers in China and India that report little by product, and for the split of certified against non-certified volume. Published estimates for this market differ widely, reflecting differing definitions of bio-based content. A revision would follow a sustained fall in oil prices, a change in renewable content rules, or delays to announced capacity. A range of plus or minus 15 percent around the base-year total is reasonable.

Scope

Questions This Report Answers

6 questions
01

What is the market size and growth rate, globally and by region?

02

How is the market segmented, and which segments lead?

03

Which regions and countries are covered, and how do they compare?

04

What are the key drivers, restraints, opportunities and challenges?

05

Who are the leading companies operating in this market?

06

What trends are expected to shape the market through the forecast period?

Questions

Frequently Asked Questions

01What is the Bio-based Propylene Glycol Market projected to reach?

USD 9.8 USD Billion by 2034, CAGR 7.99%

02What years does this report cover?

Study period 2020–2034, base year 2025, historical data 2020-2024, forecast period 2026-2034.

03Which regions are covered?

North America, Europe, Asia Pacific, Latin America, Middle East and Africa.

04Which region accounted for the largest market share?

Asia Pacific leads with 33% of global revenue through 2034.

05Which segment leads the market?

Glycerol (Crude and Refined) is the largest line by feedstock, at 46% of revenue in 2025.

06Who are the key companies profiled?

Archer Daniels Midland Company, Oleon NV, Global Bio-chem Technology Group Company Limited, Cargill, Incorporated, BASF SE, Mitsubishi Chemical Group Corporation, Dow Inc., Ashland Inc., Huntsman Corporation, LyondellBasell Industries N.V., SKC Co., Ltd., Repsol S.A., Temix Oleo S.r.l., Emery Oleochemicals Group, Wilmar International Limited, KLK OLEO (Kuala Lumpur Kepong Berhad), Musim Mas Holdings Pte. Ltd., Berkshire Hathaway-owned Univar Solutions Inc., Shell plc, INEOS Group Holdings S.A., Nippon Shokubai Co., Ltd., Haihang Industry Co., Ltd., Shandong Shida Shenghua Chemical Group Co., Ltd., Vantage Specialty Chemicals, Inc., Corbion N.V., Biesterfeld AG, IOI Oleochemical Industries Berhad, Pertamina (PT Pertamina Persero). Full profiles are part of the paid report.

07Can the segmentation be customized?

Yes. Custom data cuts by geography, segment, or competitor set are available on request.

425+
Dedicated research analysts
1,200+
Reports published
Why CDI

Why choose CDI

Data triangulated across primary and secondary sources
Complimentary analyst call included with every purchase
Custom data cuts and post-purchase support available

Need this report shaped around your question?

The scope isn't fixed. Tell us what your team needs that the standard edition doesn't cover, and an analyst will come back on what can be adjusted and how long it takes, before you commit to anything.

Most licences include 30–60 hours of customization at no extra cost. See what each licence includes

Request customization

Additional Companies

Add competitors, suppliers or the peer set you benchmark against to the companies already covered.

Deeper Competitive View

Sharpen the landscape work around your own position: product line, channel, or a named shortlist of rivals.

Extra Segment Splits

Break the market down along an axis the standard scope doesn't cut it by, or go a level deeper inside one.

Application Focus

Narrow the analysis to the specific use cases and end users your team actually sells into.

Different Time Frame

Move the base year, or widen the historical and forecast windows the study is built on.

Country-Level Detail

Go below region level into the individual countries that matter to you, rather than the standard geography split.